NCT06863402 2025-12-23Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma SubtypeRoswell Park Cancer InstitutePhase 2 Recruiting32 enrolled